141 related articles for article (PubMed ID: 22241190)
1. [Mucositis in head and neck cancer patients undergoing radiochemotherapy].
Santos RC; Dias RS; Giordani AJ; Segreto RA; Segreto HR
Rev Esc Enferm USP; 2011 Dec; 45(6):1338-44. PubMed ID: 22241190
[TBL] [Abstract][Full Text] [Related]
2. Daily Time of Radiation Treatment Is Associated with Subsequent Oral Mucositis Severity during Radiotherapy in Head and Neck Cancer Patients.
Gu F; Farrugia MK; Duncan WD; Feng Y; Hutson AD; Schlecht NF; Repasky EA; Antoch MP; Miller A; Platek A; Platek ME; Iovoli AJ; Singh AK
Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):949-955. PubMed ID: 32098893
[TBL] [Abstract][Full Text] [Related]
3. Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy.
Bossi P; Bergamini C; Miceli R; Cova A; Orlandi E; Resteghini C; Locati L; Alfieri S; Imbimbo M; Granata R; Mariani L; Iacovelli NA; Huber V; Cavallo A; Licitra L; Rivoltini L
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):959-966. PubMed ID: 27745982
[TBL] [Abstract][Full Text] [Related]
4. Frequency and Evolution of Acute Oral Complications in Patients Undergoing Radiochemotherapy Treatment for Head and Neck Squamous Cell Carcinoma.
Palmieri M; Sarmento DJS; Falcão AP; Martins VAO; Brandão TB; Morais-Faria K; Ribeiro ACP; Hasséus B; Giglio D; Braz-Silva PH
Ear Nose Throat J; 2021 Sep; 100(5_suppl):449S-455S. PubMed ID: 31619067
[TBL] [Abstract][Full Text] [Related]
5. Hangeshashinto improves the completion rate of chemoradiotherapy and the nutritional status in patients with head and neck cancer.
Hatakeyama H; Takahashi H; Oridate N; Kuramoto R; Fujiwara K; Homma A; Takeda H; Fukuda S
ORL J Otorhinolaryngol Relat Spec; 2015; 77(2):100-8. PubMed ID: 25896416
[TBL] [Abstract][Full Text] [Related]
6. Feasibility and toxicity of concurrent chemoradiation for elderly patients with head and neck cancer.
Daly ME; Lau DH; Farwell DG; Luu Q; Donald PJ; Chen AM
Am J Otolaryngol; 2013; 34(6):631-5. PubMed ID: 23954137
[TBL] [Abstract][Full Text] [Related]
7. Rebamipide gargle in preventive management of chemo-radiotherapy induced oral mucositis.
Chaitanya B; Pai KM; Yathiraj PH; Fernandes D; Chhaparwal Y
Oral Oncol; 2017 Sep; 72():179-182. PubMed ID: 28797456
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Nutritional Index Predicts Toxicity in Head and Neck Cancer Patients Treated with Definitive Radiotherapy in Association with Chemotherapy.
Fanetti G; Polesel J; Fratta E; Muraro E; Lupato V; Alfieri S; Gobitti C; Minatel E; Matrone F; Caroli A; Revelant A; Lionello M; Zammattio Polentin V; Ferretti A; Guerrieri R; Chiovati P; Bertolin A; Giacomarra V; Paoli A; Vaccher E; Sartor G; Steffan A; Franchin G
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33924581
[TBL] [Abstract][Full Text] [Related]
9. L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial.
Tsujimoto T; Yamamoto Y; Wasa M; Takenaka Y; Nakahara S; Takagi T; Tsugane M; Hayashi N; Maeda K; Inohara H; Uejima E; Ito T
Oncol Rep; 2015 Jan; 33(1):33-9. PubMed ID: 25351453
[TBL] [Abstract][Full Text] [Related]
10. Comparison of acute toxicities associated with cetuximab-based bioradiotherapy and platinum-based chemoradiotherapy for head and neck squamous cell carcinomas: A single-institution retrospective study in Japan.
Sakashita T; Homma A; Hatakeyama H; Furusawa J; Kano S; Mizumachi T; Iizuka S; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
Acta Otolaryngol; 2015 Aug; 135(8):853-8. PubMed ID: 25814008
[TBL] [Abstract][Full Text] [Related]
11. Survey of pre-inflammation cytokines levels in radiotherapy-induced-mucositis.
Seyyednejad F; Rezaee A; Haghi S; Goldust M
Pak J Biol Sci; 2012 Nov; 15(22):1098-101. PubMed ID: 24261128
[TBL] [Abstract][Full Text] [Related]
12. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
[TBL] [Abstract][Full Text] [Related]
13. N-Acetylcysteine Rinse for Thick Secretion and Mucositis of Head and Neck Chemoradiotherapy (Alliance MC13C2): A Double-Blind Randomized Clinical Trial.
Sio TT; Blanchard MJ; Novotny PJ; Patel SH; Rwigema JM; Pederson LD; McGee LA; Gamez ME; Seeger GR; Martenson JA; Grover Y; Neben Wittich MA; Garces YI; Foote RL; Miller RC; Halyard MY
Mayo Clin Proc; 2019 Sep; 94(9):1814-1824. PubMed ID: 31405750
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin-3-gallate mouthwash protects mucosa from radiation-induced mucositis in head and neck cancer patients: a prospective, non-randomised, phase 1 trial.
Zhu W; Mei H; Jia L; Zhao H; Li X; Meng X; Zhao X; Xing L; Yu J
Invest New Drugs; 2020 Aug; 38(4):1129-1136. PubMed ID: 31701429
[TBL] [Abstract][Full Text] [Related]
15. Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer.
Yokota T; Onoe T; Ogawa H; Hamauchi S; Iida Y; Kamijo T; Suda T; Yurikusa T; Nishimura T; Yasui H; Onitsuka T
Jpn J Clin Oncol; 2015 Feb; 45(2):183-8. PubMed ID: 25420692
[TBL] [Abstract][Full Text] [Related]
16. [The timing of the appearance of oral mucositis induced by concurrent chemoradiotherapy with S-1 for head and neck cancer].
Yonekita H; Takase H; Ogata K; Futagami K; Nomoto S; Yoshimitsu K; Nakagawa T; Tokunaga S
Gan To Kagaku Ryoho; 2014 Dec; 41(13):2571-5. PubMed ID: 25596050
[TBL] [Abstract][Full Text] [Related]
17. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.
Bentzen SM; Saunders MI; Dische S; Bond SJ
Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.
Hamauchi S; Yokota T; Onozawa Y; Ogawa H; Onoe T; Kamijo T; Iida Y; Nishimura T; Onitsuka T; Yasui H
Jpn J Clin Oncol; 2015 Dec; 45(12):1116-21. PubMed ID: 26423341
[TBL] [Abstract][Full Text] [Related]
20. IMRT with simultaneous integrated boost and concurrent chemotherapy for locoregionally advanced squamous cell carcinoma of the head and neck.
Montejo ME; Shrieve DC; Bentz BG; Hunt JP; Buchman LO; Agarwal N; Hitchcock YJ
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e845-52. PubMed ID: 21167654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
